MBNL1 and myotonic dystrophy type 1: These results suggest that while boldine reduces the focal formation in the myoblasts of DM1 patients, this ability it is not connected to the recovery of free MBNL1 levels in the nucleus, potentially limiting its further activity on the downstream connected disease features, such as AS.